MedTrace Logo

Mortality Reduction in Septic Shock by Plasma Adsorption

NCT02357433 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-07-06

No results posted yet for this study

Summary

The study objective is to clarify whether the application of high doses CPFA (Coupled Plasma-Filtration Adsorption) in addition to the current clinical practice is able to reduce hospital mortality in septic shock patients in intensive care unit (ICU).

Conditions

  • Septic Shock

Interventions

DEVICE

High Doses CPFA

Sponsors & Collaborators

  • Francisco Colomina Climent

    lead OTHER

Principal Investigators

  • Francisco Colomina, MD · Hospital Universitario de San Juan de Alicante

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02357433 on ClinicalTrials.gov